{"id":"mesenchymal-stem-cells-mscs","safety":{"commonSideEffects":[{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL5315110","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"MSCs are multipotent stromal cells that suppress pro-inflammatory immune responses, promote tissue regeneration, and secrete cytokines and growth factors that reduce inflammation and support healing. They can differentiate into multiple cell types (osteocytes, chondrocytes, adipocytes) and modulate both innate and adaptive immunity through interaction with T cells, B cells, and macrophages. The therapeutic benefit derives from both their regenerative capacity and their ability to create an immunologically permissive microenvironment.","oneSentence":"Mesenchymal stem cells exert therapeutic effects through immunomodulation, anti-inflammatory signaling, and tissue repair via paracrine secretion of bioactive factors and direct cell-to-cell interactions.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:54:28.150Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Graft-versus-host disease (GVHD)"},{"name":"Osteoarthritis"},{"name":"Myocardial infarction"},{"name":"Spinal cord injury"}]},"trialDetails":[{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT07495956","phase":"PHASE1, PHASE2","title":"cfMSC Therapy for Diabetes","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2026-03-16","conditions":"Type II Diabetes Mellitus","enrollment":30},{"nctId":"NCT07477600","phase":"PHASE1, PHASE2","title":"cfMSC Stem Cell Therapy Targeting COPD","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2026-03-10","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":30},{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT07339111","phase":"PHASE3","title":"Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis","status":"RECRUITING","sponsor":"Medipost, Inc.","startDate":"2026-03-11","conditions":"Knee Cartilage Defects","enrollment":300},{"nctId":"NCT07480161","phase":"PHASE2, PHASE3","title":"Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-12-29","conditions":"Erectile Dysfunction With Diabetes Mellitus","enrollment":90},{"nctId":"NCT04749667","phase":"PHASE1, PHASE2","title":"Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2021-08-09","conditions":"Multiple Sclerosis, Progressive Multiple Sclerosis","enrollment":18},{"nctId":"NCT00683722","phase":"PHASE2","title":"PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-03-20","conditions":"Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Chronic Bronchitis","enrollment":62},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT04565665","phase":"PHASE1, PHASE2","title":"Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-29","conditions":"COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":70},{"nctId":"NCT07238062","phase":"","title":"\"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy.\"","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Multiple System Atrophy","enrollment":""},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT07439848","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2023-12-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":15},{"nctId":"NCT07441226","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients","status":"RECRUITING","sponsor":"RSUP Persahabatan","startDate":"2025-08-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":20},{"nctId":"NCT05008588","phase":"PHASE1, PHASE2","title":"Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-05-30","conditions":"Ischemic Stroke","enrollment":15},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT04314661","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2020-08-03","conditions":"Osteoarthritis, Knee","enrollment":31},{"nctId":"NCT04357600","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B","status":"ENROLLING_BY_INVITATION","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2018-05-17","conditions":"Liver Cirrhoses","enrollment":12},{"nctId":"NCT07413549","phase":"PHASE1, PHASE2","title":"Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis","status":"RECRUITING","sponsor":"Beijing Tuohua Weiye Biotechnology Co., Ltd.","startDate":"2025-02-25","conditions":"Decompensated Hepatitis B Cirrhosis","enrollment":76},{"nctId":"NCT07409259","phase":"EARLY_PHASE1","title":"PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2026-01-01","conditions":"Acute-on-Chronic Liver Failure (ACLF)","enrollment":20},{"nctId":"NCT07299123","phase":"PHASE1, PHASE2","title":"Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese PLA General Hospital","startDate":"2023-08-01","conditions":"Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia","enrollment":40},{"nctId":"NCT07396155","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-07-01","conditions":"Diabetic Nephropathy Type 2","enrollment":10},{"nctId":"NCT05820711","phase":"PHASE1","title":"Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2023-07-17","conditions":"Head and Neck Cancer, Xerostomia","enrollment":23},{"nctId":"NCT07304440","phase":"PHASE1, PHASE2","title":"Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study","status":"RECRUITING","sponsor":"Adia Med of Winter Park LLC","startDate":"2026-01-12","conditions":"Autism Spectrum Disorder, Autism, ASD","enrollment":100},{"nctId":"NCT02633163","phase":"PHASE2","title":"Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2018-11-18","conditions":"Systemic Lupus Erythematosus","enrollment":81},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT05095532","phase":"PHASE1","title":"Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2021-12-01","conditions":"Chronic Pancreatitis, Mesenchymal Stem Cells","enrollment":42},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT06726538","phase":"PHASE1, PHASE2","title":"Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2023-10-01","conditions":"Female Sexual Dysfunction","enrollment":50},{"nctId":"NCT04312113","phase":"PHASE1","title":"Angiographic Delivery of AD-MSC for Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-11-16","conditions":"Ulcerative Colitis","enrollment":20},{"nctId":"NCT06001853","phase":"PHASE2","title":"Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-11-03","conditions":"Facet-Mediated Low Back Pain","enrollment":40},{"nctId":"NCT06981741","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint","status":"RECRUITING","sponsor":"BIONCaRT GmbH","startDate":"2025-11-10","conditions":"Cartilage Damage","enrollment":55},{"nctId":"NCT07329569","phase":"PHASE2","title":"Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2026-03","conditions":"Chemical Burns, Ocular Burns","enrollment":21},{"nctId":"NCT05491681","phase":"PHASE1","title":"AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial","status":"WITHDRAWN","sponsor":"BioCardia, Inc.","startDate":"2026-01-04","conditions":"ARDS, Human","enrollment":""},{"nctId":"NCT02962661","phase":"PHASE1","title":"Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-18","conditions":"Cardiomyopathy, Heart Failure, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":72},{"nctId":"NCT04650568","phase":"NA","title":"Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction","status":"ENROLLING_BY_INVITATION","sponsor":"Rush University Medical Center","startDate":"2017-11-03","conditions":"Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture","enrollment":100},{"nctId":"NCT07313020","phase":"EARLY_PHASE1","title":"Handheld MPI Imaging to Track Stem Cells in Osteoarthritis","status":"ENROLLING_BY_INVITATION","sponsor":"Soochow University","startDate":"2025-12-16","conditions":"Knee Arthritis Osteoarthritis","enrollment":10},{"nctId":"NCT07305623","phase":"PHASE3","title":"Safety and Efficacy of Bone Bioengineering Kit With Stem Cells for Alveolar Cleft Repair","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Tecnologia do Paraná","startDate":"2026-07","conditions":"Cleft Lip Palate","enrollment":205},{"nctId":"NCT07240987","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells for Chronic Kidney Diseases","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Air Force Medicial University","startDate":"2026-01-01","conditions":"Kidney Disease, Chronic, Diabetic Kidney Disease (DKD), Hypertensive Nephropathy","enrollment":32},{"nctId":"NCT06328712","phase":"PHASE1","title":"Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A","status":"COMPLETED","sponsor":"ENCell","startDate":"2024-05-30","conditions":"Charcot-Marie-Tooth Disease Type 1A","enrollment":6},{"nctId":"NCT05080465","phase":"PHASE3","title":"Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis","status":"COMPLETED","sponsor":"Ukraine Association of Biobank","startDate":"2018-12-02","conditions":"Liver Cirrhosis","enrollment":700},{"nctId":"NCT05705024","phase":"PHASE2","title":"Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2023-09-29","conditions":"Corneal Ulcer","enrollment":38},{"nctId":"NCT05925608","phase":"PHASE1, PHASE2","title":"Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioCardia, Inc.","startDate":"2023-08-23","conditions":"Heart Failure, Systolic","enrollment":39},{"nctId":"NCT05643638","phase":"PHASE2","title":"A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD","status":"RECRUITING","sponsor":"Cynata Therapeutics Limited","startDate":"2024-03-04","conditions":"Graft Versus Host Disease, Acute","enrollment":60},{"nctId":"NCT06589271","phase":"PHASE1","title":"SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Lumbar Disc Degeneration","enrollment":20},{"nctId":"NCT06503471","phase":"PHASE1","title":"SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Infertility, Female","enrollment":24},{"nctId":"NCT07018739","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2026-06","conditions":"Hypoxic-Ischemic Encephalopathy, Neonatal, Brain Injuries, Hypoxic-Ischemic","enrollment":40},{"nctId":"NCT07232147","phase":"PHASE1","title":"Clinical Research on Stem Cell Therapy for Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.","startDate":"2025-12-01","conditions":"Parkinson Disease (PD), Neurodegenerative Diseases, Movement Disorders","enrollment":20},{"nctId":"NCT03608579","phase":"PHASE1","title":"Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-11-05","conditions":"Osteoarthritis, Hip","enrollment":24},{"nctId":"NCT05559801","phase":"PHASE1, PHASE2","title":"Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III","enrollment":12},{"nctId":"NCT05789394","phase":"PHASE1","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-06-16","conditions":"Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Astrocytoma, Grade IV","enrollment":20},{"nctId":"NCT03477942","phase":"PHASE1","title":"Impact of Mesenchymal Stem Cells in Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2018-10-01","conditions":"Musculoskeletal Pain, Knee Osteoarthritis, Cartilage Injury","enrollment":16},{"nctId":"NCT04907188","phase":"","title":"Individual Patient Expanded Access IND for the Treatment of Stroke","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Stroke, Stroke, Ischemic","enrollment":""},{"nctId":"NCT04064957","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Spinal Cord Injuries","enrollment":""},{"nctId":"NCT07084012","phase":"PHASE2","title":"A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS","status":"RECRUITING","sponsor":"Shenzhen Wingor Biotechnology Co., Ltd.","startDate":"2025-08-27","conditions":"Acute Ischemic Stroke AIS","enrollment":60},{"nctId":"NCT04029896","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Cerebral Palsy","enrollment":""},{"nctId":"NCT04825626","phase":"","title":"An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":""},{"nctId":"NCT07197606","phase":"PHASE2","title":"Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2025-10-01","conditions":"Ischemic Stroke","enrollment":86},{"nctId":"NCT04604288","phase":"","title":"Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Knee Pain Chronic, Osteo Arthritis Knee","enrollment":""},{"nctId":"NCT04772378","phase":"","title":"Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT04514952","phase":"","title":"Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Amyotrophic Lateral Sclerosis","enrollment":""},{"nctId":"NCT03925649","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences LLC","startDate":"","conditions":"Spinal Cord Injury at C5-C7 Level","enrollment":""},{"nctId":"NCT04798066","phase":"","title":"Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Post COVID-19 Syndrome","enrollment":""},{"nctId":"NCT04711811","phase":"","title":"Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Chronic Pain","enrollment":""},{"nctId":"NCT05116540","phase":"PHASE2","title":"Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-11-24","conditions":"Multiple Sclerosis","enrollment":24},{"nctId":"NCT04362189","phase":"PHASE2","title":"Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19","status":"TERMINATED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-06-30","conditions":"COVID-19","enrollment":48},{"nctId":"NCT03691909","phase":"PHASE1, PHASE2","title":"Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Hope Biosciences LLC","startDate":"2018-09-25","conditions":"Rheumatoid Arthritis","enrollment":15},{"nctId":"NCT02685098","phase":"PHASE1","title":"A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-01-23","conditions":"Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease","enrollment":81},{"nctId":"NCT07183761","phase":"PHASE2","title":"A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects With Moderate to Severe Diabetic Peripheral Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Min Long","startDate":"2025-10-01","conditions":"Diabetic Peripheral Neuropathy (DPN)","enrollment":140},{"nctId":"NCT07106229","phase":"PHASE3","title":"A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee.","status":"NOT_YET_RECRUITING","sponsor":"Magellan Stem Cells","startDate":"2025-11","conditions":"Knee Osteoarthristis","enrollment":573},{"nctId":"NCT03211793","phase":"PHASE1, PHASE2","title":"Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2021-10-06","conditions":"Systemic Sclerosis, Digital Ulcer","enrollment":20},{"nctId":"NCT05854641","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Peripheral Arterial Disease","enrollment":10},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT03042143","phase":"PHASE1, PHASE2","title":"Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Belfast Health and Social Care Trust","startDate":"2019-01-07","conditions":"Acute Respiratory Distress Syndrome","enrollment":129},{"nctId":"NCT03123458","phase":"PHASE1","title":"Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders","status":"ENROLLING_BY_INVITATION","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2025-01-01","conditions":"Immune Related Disorder, Tissue Damage","enrollment":100},{"nctId":"NCT07157891","phase":"EARLY_PHASE1","title":"Investigating the Safety and Regenerative Potential of MSC-Derived Secretome Combined With PRGF in Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"University of the Punjab","startDate":"2025-12-10","conditions":"Osteoarthritis (OA), Knee Injury, Cartilage Degeneration","enrollment":25},{"nctId":"NCT04776239","phase":"PHASE1, PHASE2","title":"Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)","status":"COMPLETED","sponsor":"Joshua M Hare","startDate":"2021-08-16","conditions":"Diabetes Mellitus, Ischemic Heart Disease","enrollment":26},{"nctId":"NCT06167473","phase":"NA","title":"Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD","status":"ACTIVE_NOT_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-11-28","conditions":"End-stage Liver Diseases","enrollment":22},{"nctId":"NCT07146087","phase":"EARLY_PHASE1","title":"Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis","status":"SUSPENDED","sponsor":"Biocells Medical","startDate":"2020-07-01","conditions":"Multiple Sclerosis","enrollment":20},{"nctId":"NCT04042844","phase":"PHASE2","title":"A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)","status":"RECRUITING","sponsor":"BioRestorative Therapies","startDate":"2022-06-30","conditions":"Lumbar Disc Disease","enrollment":99},{"nctId":"NCT06789302","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Global Institute of Stem Cell Therapy and Research","startDate":"2025-12","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":120},{"nctId":"NCT07131150","phase":"PHASE2","title":"Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis","status":"NOT_YET_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-08-31","conditions":"Idiopathic Pulmonary Fibrosis (IPF)","enrollment":66},{"nctId":"NCT05939167","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage","status":"RECRUITING","sponsor":"Cell Energy Life Sciences Group Co. LTD","startDate":"2023-12-10","conditions":"AIDS","enrollment":150},{"nctId":"NCT07115082","phase":"PHASE1, PHASE2","title":"Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency","status":"RECRUITING","sponsor":"Yan Hongli","startDate":"2024-10-15","conditions":"Premature Ovarian Insufficiency","enrollment":50},{"nctId":"NCT05925036","phase":"PHASE1","title":"Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-01-01","conditions":"Chronic Pancreatitis, Chronic Pain","enrollment":40},{"nctId":"NCT06205342","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-07-17","conditions":"Chronic Pancreatitis, Chronic Pain","enrollment":48},{"nctId":"NCT05027581","phase":"PHASE2","title":"Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)","status":"COMPLETED","sponsor":"Taiwan Bio Therapeutics Inc.","startDate":"2021-10-13","conditions":"Osteoarthritis, Knee","enrollment":72},{"nctId":"NCT04297813","phase":"PHASE3","title":"Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting","status":"COMPLETED","sponsor":"University of Bergen","startDate":"2020-03-12","conditions":"Alveolar Bone Atrophy","enrollment":48},{"nctId":"NCT07041801","phase":"PHASE1, PHASE2","title":"Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"Shenzhen Beike Bio-Technology Co., Ltd.","startDate":"2025-06-28","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":58},{"nctId":"NCT03522545","phase":"PHASE1","title":"Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-04-20","conditions":"Treatment-resistant Bipolar Depression","enrollment":30},{"nctId":"NCT03355365","phase":"PHASE2","title":"Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Tisch Multiple Sclerosis Research Center of New York","startDate":"2018-09-21","conditions":"Multiple Sclerosis","enrollment":54},{"nctId":"NCT07010926","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"L2 Bio, LLC","startDate":"2025-08-15","conditions":"Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)","enrollment":120},{"nctId":"NCT07011199","phase":"PHASE1","title":"Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia","status":"NOT_YET_RECRUITING","sponsor":"Universitas Diponegoro","startDate":"2025-06-17","conditions":"Biliary Atresia, Kasai Portoenterostomy, Mesenchymal Stem Cell Transplantation","enrollment":14},{"nctId":"NCT06030648","phase":"PHASE1","title":"MT2022-01: MSCs for ALD","status":"SUSPENDED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2023-08-28","conditions":"Cerebral Adrenoleukodystrophy","enrollment":10},{"nctId":"NCT06996392","phase":"PHASE1","title":"Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2025-05-07","conditions":"Acute-On-Chronic Liver Failure","enrollment":15},{"nctId":"NCT06981338","phase":"PHASE1, PHASE2","title":"Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation","status":"NOT_YET_RECRUITING","sponsor":"Institut Guttmann","startDate":"2025-09-01","conditions":"Spinal Cord Injuries (SCI), Spinal Cord Injury, Traumatic Spinal Cord Injuries","enrollment":10},{"nctId":"NCT05039411","phase":"PHASE1","title":"Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease","status":"RECRUITING","sponsor":"CryoCord Sdn Bhd","startDate":"2022-03-01","conditions":"Perianal Fistula Due to Crohn's Disease, Fistula in Ano","enrollment":5},{"nctId":"NCT04061746","phase":"PHASE1","title":"Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2020-02-27","conditions":"Diabetes Mellitus, Type 1","enrollment":60},{"nctId":"NCT06951074","phase":"PHASE2, PHASE3","title":"Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Stem Cells, Type 1 Diabetes","enrollment":20},{"nctId":"NCT04447833","phase":"PHASE1","title":"Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Uppsala University","startDate":"2020-06-17","conditions":"ARDS, Human, COVID","enrollment":7}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":21992,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (MSCs)","Allogeneic Bone Marrow Derived Mesenchymal Stem Cells","MSV (GMP-compliant MSCs manufactured by IBGM in Valladolid)"],"phase":"marketed","status":"active","brandName":"Mesenchymal Stem Cells (MSCs)","genericName":"Mesenchymal Stem Cells (MSCs)","companyName":"The Cleveland Clinic","companyId":"the-cleveland-clinic","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mesenchymal stem cells exert therapeutic effects through immunomodulation, anti-inflammatory signaling, and tissue repair by secreting bioactive factors and differentiating into specialized cell types. Used for Graft-versus-host disease (GVHD), Osteoarthritis, Myocardial infarction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}